Physician

Alexandra Jubran

According to 2025 Medicare claims, Alexandra Jubran (NPI: 1851824692) practices osteopathic manipulative therapy in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is SHARP REES-STEALY MEDICAL GROUP, INC (NPI: 1285616177; TIN: 330106028) and primary practice location at 91942-3014. Jubran is affiliated with the Sharp Rees-Stealy Medical Group (ACO ID: A5521), participating under the MSSP model.

Jubran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 104 traditional Medicare patients, billed 1,637 HCPCS/CPT codes, and received $24,921 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,724 prescription claims across 526 beneficiaries totaling $332,473 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 5 records totaling $110. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$12K$25K2021 Medicare payment: $17,692 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $21,554 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $22,186 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $24,921 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021120483$17,692
2022130323$21,554
2023119839$22,186
20241041,637$24,921

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$167K$335K2021 Drug cost: $74,521 (USD; Tot_Drug_Cst)2022 Drug cost: $218,979 (USD; Tot_Drug_Cst)2023 Drug cost: $334,520 (USD; Tot_Drug_Cst)2024 Drug cost: $332,473 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021199919$74,521
20223332,813$218,979
20234413,912$334,520
20245263,724$332,473

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more60117$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4353$60

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin422,776$53,890
EliquisApixaban392,072$39,397
OzempicSemaglutide281,246$37,156
XareltoRivaroxaban131,110$20,909
JanuviaSitagliptin Phosphate11930$16,993

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$110Novo Nordisk Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexandra Jubran?

Tedicare shows public-source Medicare data for Alexandra Jubran (NPI 1851824692), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra Jubran have ACO affiliation data?

Alexandra Jubran is shown with ACO affiliation data for Sharp Rees-Stealy Medical Group (MSSP, ACO ID A5521).

What billing organization is linked to Alexandra Jubran?

Alexandra Jubran is linked to SHARP REES-STEALY MEDICAL GROUP, INC (billing NPI 1285616177) in the available physician profile data.

Does Alexandra Jubran have Open Payments data?

Alexandra Jubran has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.